Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

The TensorFlow Model Garden is Google’s open-source hub for high-performance machine learning models in vision and NLP, offering both official and research implementations. It provides a powerful ...

There comes a time before every big purchase when you might ask yourself, “Do I really need this?” If you don’t pause for a moment — and if you tend to blow your budget as a result — then you need to ...

Grass-roots initiatives such as the 1000 Functional Connectomes Project (FCP) and International Neuroimaging Data- sharing Initiative (INDI) [1] are successfully amassing and sharing large-scale brain ...

Chart Industries (NYSE:GTLS) was named as a Top Pick by Morgan Stanley analysts Friday following its $19B all-stock merger with Flowserve (FLS), which the bank said should further boost what already ...

ABSTRACT: Pregnancy presents a unique clinical scenario where the safety of pharmacological interventions is of paramount importance. The potential teratogenic risks associated with drug intake during ...

June 4 (Reuters) - U.S.-based equipment manufacturer Chart Industries (GTLS.N), opens new tab and flow control systems maker Flowserve Corp (FLS.N), opens new tab agreed to merge in an all-stock deal, ...

Chart Industries (NYSE:GTLS) and Flowserve (NYSE:FLS) said Wednesday they agreed to combine in an all-stock merger valued at ~$19B including debt, creating a differentiated leader in industrial ...

Shares of Chart Industries and Flowserve moved lower in premarket trading Wednesday after the companies agreed to combine in an all-stock merger. Under the agreement, Chart shareholders will receive 3 ...